<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Maternal adaptations to pregnancy: Skin and related structures</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Maternal adaptations to pregnancy: Skin and related structures</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Maternal adaptations to pregnancy: Skin and related structures</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Miriam Keltz Pomeranz, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Charles J Lockwood, MD, MHCM</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert P Dellavalle, MD, PhD, MSPH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Vanessa A Barss, MD, FACOG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jun 12, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The maternal skin and related structures, including glands, hair, nails, and mucosa, undergo numerous changes during pregnancy and the puerperium. The normal physiological alterations in skin during pregnancy are reviewed here  (<a class="graphic graphic_table graphicRef78973" href="/d/graphic/78973.html" rel="external">table 1</a>). Pathologic cutaneous changes and their management are discussed separately. (See  <a class="medical medical_review" href="/d/html/5564.html" rel="external">"Dermatoses of pregnancy"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">SKIN</span><span class="headingEndMark"> — </span>The overall clinical appearance of skin is related to pigmentation, glands, vasculature, and connective tissue. Cutaneous changes during pregnancy are best understood by examining each of these different aspects of skin structure.</p><p class="headingAnchor" id="H3"><span class="h2">Hyperpigmentation</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Changes in pregnancy</strong> – Almost all pregnant people develop increased skin pigmentation.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The increased pigmentation usually occurs in discrete, localized areas, possibly because of regional differences in melanocyte density within the epidermis [<a href="#rid1">1,2</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Generalized hyperpigmentation may occur [<a href="#rid3">3-5</a>], but is rarely caused by pregnancy alone, so other causes, such as Addison's disease, should be considered. (See  <a class="medical medical_review" href="/d/html/159.html" rel="external">"Clinical manifestations of adrenal insufficiency in adults", section on 'Hyperpigmentation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathogenesis</strong> – The pathogenesis of the increased pigmentation related to pregnancy is not completely understood. One possibility is that estrogens and progesterone cause melanocytic stimulation [<a href="#rid6">6-8</a>]. However, the pigmentary changes occur early in pregnancy and before a rise in alpha-melanocyte stimulating hormone plasma levels, which occurs in late gestation [<a href="#rid9">9</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical findings </strong>–<strong> </strong>Increased pigmentation is common and occurs in the following areas: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Facial skin (ie, melasma). (See <a class="local">'Melasma'</a> below.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Midline skin, which becomes the linea nigra [<a href="#rid10">10</a>]. The increased pigmentation may span from the pubic symphysis to the xiphoid process.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Periareolar skin, extending outward in a net-like array, referred to as the secondary areola [<a href="#rid6">6</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Nipples, axillae, genitalia, perineum, anus, inner thighs, and neck [<a href="#rid11">11</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Recent scars, freckles, and lentigines [<a href="#rid3">3,6</a>].</p><p></p><p class="bulletIndent1">In addition, pigmentary demarcation lines may become visible during pregnancy. These areas of sharp delineation between naturally more pigmented and less pigmented skin are reported most commonly on the legs of pregnant Japanese and Black patients [<a href="#rid12">12</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Postpartum course</strong> – Hyperpigmented areas become less pigmented over a period of several months.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment</strong> – Postpartum patients who are bothered by persistent hyperpigmentation may desire treatment. (See  <a class="medical medical_review" href="/d/html/89268.html" rel="external">"Acquired hyperpigmentation disorders", section on 'General principles of treatment'</a>.)</p><p></p><p class="headingAnchor" id="H5"><span class="h2">Melasma</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Course in pregnancy</strong> – Melasma (ie, chloasma or mask of pregnancy) is the most cosmetically disturbing pigmentary change in pregnancy and occurs in up to 75 percent of pregnant people [<a href="#rid8">8</a>]. The characteristic hyperpigmentation of the face may also occur in individuals taking oral contraceptive pills.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk factors</strong> – Risk factors and trigger factors include: genetic predisposition, exposure to sunlight (including ultraviolet and, possibly, visible light), skin phototype, and hormonal factors (including pregnancy, hormonal therapies, and use of oral contraceptives) [<a href="#rid7">7</a>]. Solar irradiation is important in maintaining the hyperpigmentation [<a href="#rid6">6,7</a>], thus, protection from the sun (including use of broad-spectrum sunscreens with sun protection factor [SPF] of 50 or higher) is an essential part of a preventive treatment regimen [<a href="#rid7">7,13</a>]. (See  <a class="medical medical_review" href="/d/html/121155.html" rel="external">"Melasma: Epidemiology, pathogenesis, clinical presentation, and diagnosis", section on 'Risk and trigger factors'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical findings</strong> – The three clinical melasma patterns are [<a href="#rid7">7</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Centrofacial – Involving the cheeks  (<a class="graphic graphic_picture graphicRef64109" href="/d/graphic/64109.html" rel="external">picture 1</a>), forehead  (<a class="graphic graphic_picture graphicRef75884" href="/d/graphic/75884.html" rel="external">picture 2</a>), upper lip  (<a class="graphic graphic_picture graphicRef52220" href="/d/graphic/52220.html" rel="external">picture 3</a>), nose and chin </p><p class="bulletIndent2"><span class="glyph">•</span>Malar – Involving the cheeks and nose  (<a class="graphic graphic_picture graphicRef122095" href="/d/graphic/122095.html" rel="external">picture 4</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Mandibular – Involving the ramus of the mandible  (<a class="graphic graphic_picture graphicRef122097" href="/d/graphic/122097.html" rel="external">picture 5</a>)</p><p></p><p class="bulletIndent1">There is conflicting information about the frequency of each type [<a href="#rid6">6,14</a>]. It is possible that differences in skin pigmentation, as well as different climates, play a role in which pattern is more common. (See  <a class="medical medical_review" href="/d/html/121155.html" rel="external">"Melasma: Epidemiology, pathogenesis, clinical presentation, and diagnosis", section on 'Clinical presentation'</a> and  <a class="medical medical_review" href="/d/html/121155.html" rel="external">"Melasma: Epidemiology, pathogenesis, clinical presentation, and diagnosis", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Postpartum course</strong> – Melasma related to pregnancy usually regresses within one year [<a href="#rid3">3</a>]. However, some areas of hyperpigmentation may never completely resolve [<a href="#rid13">13</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment</strong> – Postpartum patients who are bothered by persistent melasma may desire treatment. Options include topical skin-lightening agents, oral <a class="drug drug_general" data-topicid="10011" href="/d/drug information/10011.html" rel="external">tranexamic acid</a>, chemical peels, and laser and light therapies. (See  <a class="medical medical_review" href="/d/html/6621.html" rel="external">"Melasma: Management"</a>.)</p><p></p><p class="headingAnchor" id="H1218169218"><span class="h2">Nevi</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Course in pregnancy</strong> – Although nevi may change during pregnancy, changes are not significantly different than in nonpregnant individuals, except perhaps in patients with dysplastic nevus syndrome [<a href="#rid15">15</a>]. In one study, 75 percent of patients with dysplastic nevus syndrome had a change in nevi during pregnancy, and this rate of clinical change was nearly fourfold greater than that in these same patients when not pregnant [<a href="#rid16">16</a>].</p><p></p><p class="bulletIndent1">In patients without dysplastic nevus syndrome, increases in size during pregnancy occur on expanding skin (such as abdomen and breasts) but not at other sites [<a href="#rid17">17</a>]. Color changes during pregnancy are similar to color changes in the nonpregnant state [<a href="#rid18">18</a>]. Dermatoscopic features of nevi may change during pregnancy, but not in a way that suggests melanoma [<a href="#rid15">15,19</a>]. Similarly, although some studies have shown histologic changes in nevi that were attributed to pregnancy, these changes were not suggestive of melanoma and did not lead to diagnostic confusion [<a href="#rid15">15,20-22</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation and treatment</strong> – All nevi that change in a manner that would raise concern in the nonpregnant patient should be examined histologically in the pregnant patient [<a href="#rid15">15</a>]. (See  <a class="medical medical_review" href="/d/html/4846.html" rel="external">"Acquired melanocytic nevi (moles)"</a> and  <a class="medical medical_review" href="/d/html/13519.html" rel="external">"Atypical (dysplastic) nevi"</a>.)</p><p></p><p class="headingAnchor" id="H6"><span class="h2">Vascular changes</span><span class="headingEndMark"> — </span>Estrogen and other pregnancy-related factors cause vascular distention, vascular instability, and proliferation of blood vessels during pregnancy. These vascular alterations result in the numerous changes in skin, which are described in the following sections and usually regress postpartum [<a href="#rid1">1,23,24</a>].</p><p class="headingAnchor" id="H276253908"><span class="h3">Vascular spiders</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Course in pregnancy</strong> – Vascular spiders (eg, spider angiomas, nevi aranei, spider nevi, arterial spiders, spider telangiectasia)  (<a class="graphic graphic_picture graphicRef74047" href="/d/graphic/74047.html" rel="external">picture 6</a>) develop in approximately 66 percent of light-skinned and 11 percent of dark-skinned pregnant people, typically appearing in the second to fifth month of pregnancy [<a href="#rid13">13</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical findings</strong> – The lesions are red with branches extending out from a central puncta. They are most common around the eyes and occur almost exclusively in areas drained by the superior vena cava: neck, face, upper chest, arms, and hands [<a href="#rid6">6,10</a>]. Lesions in a dermatomal distribution, termed unilateral nevoid telangiectasia or unilateral dermatomal superficial telangiectasia, may appear during pregnancy, as well [<a href="#rid25">25</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Postpartum course</strong> – Most lesions (90 percent) regress by three months postpartum [<a href="#rid6">6,13</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment</strong> – Persistent spider veins/telangiectasias of the lower extremity can be cosmetically disturbing to patients and can be treated with sclerotherapy or with lasers [<a href="#rid26">26,27</a>]. (See  <a class="medical medical_review" href="/d/html/13638.html" rel="external">"Laser and light therapy for cutaneous vascular lesions"</a>.)</p><p></p><p class="headingAnchor" id="H276253915"><span class="h3">Palmar erythema</span><span class="headingEndMark"> — </span>Palmar erythema occurs in two distributions [<a href="#rid3">3,4,6</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Limited to the hypothenar and/or thenar eminence; or</p><p class="bulletIndent1"><span class="glyph">●</span>Diffuse and mottled</p><p></p><p>Palmar erythema is observed in approximately 66 percent of light-skinned and 33 percent of dark-skinned pregnant people.</p><p class="headingAnchor" id="H276253922"><span class="h3">Varicosities</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical findings and course in pregnancy</strong> – Lower extremity, anorectal, and vulvar varicosities all occur at increased frequency during pregnancy and cannot be prevented.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Varicose veins of the lower extremity</strong> – Up to 50 percent of pregnant people experience abnormal dilation of the superficial veins of the lower extremities. The varicosities can become visible anytime during pregnancy but are most common in the third trimester. In addition to pregnancy, risk factors associated with the development of varicose veins include other high estrogen/progesterone states, advancing age, family history of venous disease, prolonged standing, increased body mass index, physical inactivity, leg trauma, and smoking.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Anorectal varicosities (hemorrhoids)</strong> – Anorectal symptoms are common in pregnancy, affecting up to 70 percent of pregnant people, and these symptoms are often related to hemorrhoids [<a href="#rid28">28-30</a>]. Pain and bleeding appear to be more common in the third trimester, whereas perianal itching seems to be distributed equally amongst the trimesters.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Vulvar varicosities</strong> – Jacquemier's sign refers to venous distention in the vestibule and vagina and is associated with vulvar varicosities, which are particularly difficult to treat [<a href="#rid3">3</a>]. The varicosities may appear like a "bag of worms" in the enlarged labia  (<a class="graphic graphic_picture graphicRef86312" href="/d/graphic/86312.html" rel="external">picture 7</a>). Vulvar varicosities may be associated with pelvic congestion syndrome. They can be misdiagnosed as cysts or masses, including disorders of the Bartholin glands [<a href="#rid31">31</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathogenesis</strong> – The etiology is partly hemodynamic, due to increased blood volume and increased venous pressure in femoral and pelvic vessels from the enlarging uterus. Hormonal changes related to pregnancy contribute by causing relaxation of the muscular walls of the blood vessels. Genetic predisposition also plays a role. Because the perineal veins do not have valves, they are susceptible to developing varices: Up to one-half of vulvar varicosities arise from an incompetent great saphenous vein, which drains the superficial and deep external pudendal veins and posteromedial tributaries.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Postpartum course</strong> – Varicosities usually regress, at least partially, postpartum.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Leg varicosities</strong> – Supportive therapy of leg varicosities includes leg elevation, compression hosiery, sleeping on the left side, exercise, and avoidance of long periods of standing or sitting. Medical or surgical intervention can be considered three to six months after giving birth and depends on the clinical severity and nature of underlying venous reflux, as well as the patient's future childbearing plans. (See  <a class="medical medical_review" href="/d/html/8181.html" rel="external">"Overview of lower extremity chronic venous disease", section on 'Management'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Hemorrhoids</strong> – Adequate hydration and a diet replete with fiber may reduce constipation, which aggravates discomfort of hemorrhoids. Treatment for relief of symptoms consists of local application of antiinflammatory, antipruritic, and local anesthetic preparations. Recurrent and severe hemorrhoids usually require surgical treatment, typically hemorrhoidectomy, which can be performed safely during pregnancy if necessary. (See  <a class="medical medical_review" href="/d/html/1382.html" rel="external">"Home and office treatment of symptomatic hemorrhoids"</a> and  <a class="medical medical_review" href="/d/html/14997.html" rel="external">"Surgical treatment of hemorrhoidal disease"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Vulvar varicosities</strong> – During pregnancy, they are managed conservatively by vulvar support and compression and by avoiding prolonged standing. Symptomatic varicosities that do not resolve postpartum have been treated by sclerotherapy, excision, embolization, and ligation [<a href="#rid31">31-35</a>]. The treatment depends on the size and source of the varicosities. (See  <a class="medical medical_review" href="/d/html/5420.html" rel="external">"Vulvovaginal varicosities and pelvic congestion syndrome"</a>.)</p><p></p><p class="headingAnchor" id="H7"><span class="h3">Vascular tumors</span><span class="headingEndMark"> — </span>Vascular tumor-like structures may develop or enlarge during pregnancy.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pyogenic granulomas</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Clinical findings</strong> – Pyogenic granulomas (also known as lobular capillary hemangioma, pregnancy tumor or epulis, and granuloma gravidarum) are benign, vascular tumors with friable surfaces that develop over a few days to weeks. The small, soft, exophytic, pink or reddish purple, smooth or lobulated papules are made up of granulation tissue.</p><p></p><p class="bulletIndent2">They can occur on the oral mucous membranes or skin [<a href="#rid36">36</a>]. While the gingiva  (<a class="graphic graphic_picture graphicRef66965" href="/d/graphic/66965.html" rel="external">picture 8</a>) is the most common location, tumors of the tongue and extragingival sites (eg, lip  (<a class="graphic graphic_picture graphicRef60189" href="/d/graphic/60189.html" rel="external">picture 9</a>), fingers) have also been reported [<a href="#rid37">37</a>]. It has been estimated that approximately 2 to 5 percent of pregnant people develop intraoral pyogenic granuloma within the first five months of pregnancy [<a href="#rid38">38</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Pathogenesis</strong> – The lesion is thought to arise in response to local irritation/trauma and/or hormonal factors [<a href="#rid39">39</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Course and treatment</strong> – Pyogenic granulomas do not need to be excised during pregnancy as spontaneous resolution often occurs after giving birth [<a href="#rid6">6,13</a>]. The time to regression is unclear but can take weeks to months [<a href="#rid40">40,41</a>].</p><p></p><p class="bulletIndent2">Persistent, bothersome lesions can be excised and should be biopsied if there is uncertainty about the diagnosis. (See  <a class="medical medical_review" href="/d/html/13736.html" rel="external">"Pyogenic granuloma (lobular capillary hemangioma)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hemangiomas, angiolipomas, and angiolymphoid hyperplasia with eosinophilia </strong>–<strong> </strong>Hemangiomas, angiolipomas  (<a class="graphic graphic_picture graphicRef67098" href="/d/graphic/67098.html" rel="external">picture 10</a>),<strong> </strong>and angiolymphoid hyperplasia with eosinophilia  (<a class="graphic graphic_picture graphicRef99608" href="/d/graphic/99608.html" rel="external">picture 11</a>) have been reported to develop or enlarge during pregnancy and may regress postpartum [<a href="#rid24">24,42</a>]. (See  <a class="medical medical_review" href="/d/html/110155.html" rel="external">"Venous malformations", section on 'Glomuvenous malformations'</a> and  <a class="medical medical_review" href="/d/html/121010.html" rel="external">"Overview of vascular intervention and surgery for vascular anomalies"</a> and  <a class="medical medical_review" href="/d/html/5789.html" rel="external">"Vascular lesions in the newborn"</a>.)</p><p></p><p class="headingAnchor" id="H7415252"><span class="h3">Other vascular changes</span><span class="headingEndMark"> — </span>Other vascular changes and their effects during pregnancy include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vasomotor instability</strong>, which can cause facial flushing, pallor, hot/cold sensations, and cutis marmorata (a bluish reticulated patch on the leg exaggerated by exposure to cold) [<a href="#rid6">6</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Capillary permeability</strong>, increased hydrostatic pressure, and increased sodium and water retention, which can result in peripheral or facial edema in more than 50 percent of pregnancies [<a href="#rid3">3,6</a>]. Edema is often nonpitting.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Capillary fragility</strong> leading to purpura and pigmented purpura from extravasation of red blood cells. The lesions are purple nonblanchable, nonpalpable macules on the legs [<a href="#rid43">43</a>].</p><p></p><p class="headingAnchor" id="H8"><span class="h2">Striae gravidarum</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical findings and risk factors</strong> – Striae gravidarum (eg, "stretch marks" or striae distensae) begin as pink/violaceous linear patches in the sixth to seventh month of gestation. They are most prominent on the abdomen, breasts, and thighs but also arise on the lower back, buttocks, hips, and upper arms [<a href="#rid3">3,44</a>]. (See  <a class="medical medical_review" href="/d/html/95848.html" rel="external">"Striae distensae (stretch marks)", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/d/html/95848.html" rel="external">"Striae distensae (stretch marks)", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent1">Risk factors include a family history of striae gravidarum, higher prepregnancy body mass index and weight gain during pregnancy, and increased uterine distention from multiple gestation or polyhydramnios. (See  <a class="medical medical_review" href="/d/html/95848.html" rel="external">"Striae distensae (stretch marks)", section on 'Epidemiology and risk factors'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathogenesis</strong> – The pathogenesis of striae distensae is not well understood and is likely multifactorial. Physical factors resulting in increased tension on the skin, intrinsic alterations in skin structure or function, and hormonal factors (including estrogens, androgens, and glucocorticoids) may be involved. (See  <a class="medical medical_review" href="/d/html/95848.html" rel="external">"Striae distensae (stretch marks)", section on 'Pathogenesis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevention</strong> – Striae gravidarum are a common source of cosmetic concerns among pregnant people. Although a wide variety of creams, lotions, and ointments have been marketed to prevent or mitigate striae development, no high-quality evidence supports the efficacy of any of these interventions. (See  <a class="medical medical_review" href="/d/html/95848.html" rel="external">"Striae distensae (stretch marks)", section on 'Prevention'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Postpartum course</strong> – Striae can evolve into linear depressions, with fine wrinkles and hypopigmentation over a period of months to one or two years postpartum, but do not disappear  (<a class="graphic graphic_picture graphicRef101446" href="/d/graphic/101446.html" rel="external">picture 12</a> and <a class="graphic graphic_picture graphicRef101445" href="/d/graphic/101445.html" rel="external">picture 13</a>) [<a href="#rid3">3</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment</strong> – Treatment may be desired postpartum to improve the appearance of affected skin through reducing color or texture differences between striae and adjacent normal skin. (See  <a class="medical medical_review" href="/d/html/95848.html" rel="external">"Striae distensae (stretch marks)", section on 'Treatment'</a>.)</p><p></p><p class="headingAnchor" id="H1933547950"><span class="h2">Skin tags</span><span class="headingEndMark"> — </span>Skin tags (molluscum fibrosum gravidarum, acrochordon  (<a class="graphic graphic_picture graphicRef70871" href="/d/graphic/70871.html" rel="external">picture 14</a>)) develop on the face, neck, axillae, chest, groin, and inframammary area during the second half of pregnancy; they may regress postpartum [<a href="#rid6">6,13</a>]. (See  <a class="medical medical_review" href="/d/html/5573.html" rel="external">"Overview of benign lesions of the skin"</a> and  <a class="medical medical_review" href="/d/html/4033.html" rel="external">"Molluscum contagiosum"</a>.)</p><p class="headingAnchor" id="H2291937006"><span class="h2">Keloids, leiomyomas, dermatofibromas, and neurofibromas</span><span class="headingEndMark"> — </span>These lesions  (<a class="graphic graphic_picture graphicRef97014" href="/d/graphic/97014.html" rel="external">picture 15</a> and <a class="graphic graphic_picture graphicRef100292" href="/d/graphic/100292.html" rel="external">picture 16</a> and <a class="graphic graphic_picture graphicRef80587" href="/d/graphic/80587.html" rel="external">picture 17</a> and <a class="graphic graphic_picture graphicRef68729" href="/d/graphic/68729.html" rel="external">picture 18</a>) may enlarge during pregnancy and new neurofibromas may form [<a href="#rid6">6,25,45</a>]. (See  <a class="medical medical_review" href="/d/html/5569.html" rel="external">"Keloids and hypertrophic scars"</a> and  <a class="medical medical_review" href="/d/html/5573.html" rel="external">"Overview of benign lesions of the skin"</a> and  <a class="medical medical_review" href="/d/html/5196.html" rel="external">"Intradural nerve sheath tumors"</a>.)</p><p class="headingAnchor" id="H10"><span class="h2">Pruritus</span><span class="headingEndMark"> — </span>Pruritus in pregnant people may be physiologic, related to a flare of a disorder present prior to conception, or related to pregnancy-specific dermatoses.</p><p class="bulletIndent1"><span class="glyph">●</span>Pruritus is common, affecting up to 40 percent of pregnant people. Of these, over 60 percent have pruritus without any skin eruption or underlying cause other than pregnancy (ie, idiopathic pruritus).</p><p></p><p class="bulletIndent1">Itching localized to the abdomen is most common, though itching may also be localized elsewhere, with 5.1 percent localized to the anogenital region in one study [<a href="#rid46">46,47</a>].</p><p></p><p class="bulletIndent1">Treatment with oatmeal baths, topical steroids, antihistamines, and/or ultraviolet light helps to relieve symptoms.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Intrahepatic cholestasis if pregnancy (ICP) – Pruritus related to ICP is often generalized, but generally starts and predominates on the palms and soles and is worse at night. Right upper quadrant pain, nausea, poor appetite, sleep deprivation, or steatorrhea may occur. ICP is the only pregnancy-related dermatosis without primary skin changes. Diagnosis and treatment of ICP are discussed separately. (See  <a class="medical medical_review" href="/d/html/3560.html" rel="external">"Intrahepatic cholestasis of pregnancy"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Dermatoses – Pruritus is a common symptom of several dermatoses of pregnancy (eg, polymorphic eruption of pregnancy, atopic eruption of pregnancy, and pemphigoid gestationis). Diagnosis and treatment are reviewed separately. (See  <a class="medical medical_review" href="/d/html/5564.html" rel="external">"Dermatoses of pregnancy"</a>.)</p><p></p><p class="headingAnchor" id="H2865321"><span class="h2">Tattoos and piercing</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Potential risks of getting a new tattoo in pregnancy</strong> – Pregnant people should avoid getting a tattoo during pregnancy but can be reassured of the absence of proven pregnancy risks if the procedure is performed before they are aware of their pregnancy. Tattoo ink contains inorganic and synthetic organic pigments and is considered a cosmetic by the United States Food and Drug Administration. Cosmetics cannot contain poisonous or deleterious substances or unapproved color additives, and they should be manufactured in sanitary conditions.</p><p></p><p class="bulletIndent1">Although there are no reports of adverse pregnancy outcomes, including congenital anomalies, associated with tattooing during pregnancy, safety cannot be inferred given the range of pigments used, dermal injection rather than topical application, and lack of close oversight. Infection is the major concern and has been caused by contamination of the product as well as nonsterile performance of the tattoo [<a href="#rid48">48</a>]. (See  <a class="medical medical_review" href="/d/html/15721.html" rel="external">"Tattooing in adolescents and young adults", section on 'Health risks'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pregnancy course and complications of preexisting tattoos</strong> – Preexisting tattoos are generally unaffected by pregnancy [<a href="#rid49">49</a>]. Tattoos on the abdomen or breast can become distorted by enlargement of these areas or by surgical incisions.</p><p></p><p class="bulletIndent1">Some anesthesiologists avoid placing epidural anesthesia through a tattoo on the lower back because of theoretical risks (eg, epidermal tissue coring and carrying pigment into the epidural space, which theoretically might increase the risk of epidermal tumors or arachnoiditis [<a href="#rid50">50</a>]).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pregnancy course and complications of piercing</strong> – Piercing of the oral-nasal airway, nipple, navel, and genitalia are the most problematic areas in pregnant people. Piercings in these areas are generally removed if they are likely to interfere with a procedure (eg, intubation, cesarean or vaginal birth, breastfeeding) or become uncomfortable due to pregnancy-related changes. Metal body jewelry can conduct electric current if electrosurgery is performed [<a href="#rid51">51</a>]. (See  <a class="medical medical_review" href="/d/html/109.html" rel="external">"Body piercing in adolescents and young adults"</a> and  <a class="medical medical_review" href="/d/html/15721.html" rel="external">"Tattooing in adolescents and young adults", section on 'Health risks'</a>.)</p><p></p><p class="headingAnchor" id="H11"><span class="h1">SKIN APPENDAGES (ECCRINE, APOCRINE, AND SEBACEOUS GLANDS)</span><span class="headingEndMark"> — </span>Eccrine, apocrine, and sebaceous glands are all affected by pregnancy.</p><p class="bulletIndent1"><span class="glyph">●</span>Eccrine gland activity increases (except on the palms) primarily toward the end of pregnancy. This may lead to miliaria or generalized hyperhidrosis [<a href="#rid3">3,6</a>]. (See  <a class="medical medical_review" href="/d/html/13733.html" rel="external">"Miliaria"</a> and  <a class="medical medical_review" href="/d/html/2768.html" rel="external">"Evaluation of the patient with night sweats or generalized hyperhidrosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Apocrine gland activity decreases. This may lead to improvement in hidradenitis suppurativa and Fox-Fordyce disease [<a href="#rid3">3,6,52,53</a>]. (See  <a class="medical medical_review" href="/d/html/5575.html" rel="external">"Hidradenitis suppurativa: Pathogenesis, clinical features, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/13617.html" rel="external">"Fox-Fordyce disease (apocrine miliaria)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Sebaceous gland activity may increase in the third trimester [<a href="#rid6">6,13</a>]. Montgomery tubercles (ie, small, brown papules on the areolae consisting, in part, of hypertrophied sebaceous glands) develop in 30 to 50 percent of pregnant people and regress postpartum [<a href="#rid3">3</a>]. Increased sebaceous gland activity during pregnancy has variable effects on acne. (See  <a class="medical medical_review" href="/d/html/13615.html" rel="external">"Postadolescent acne in women"</a>.)</p><p></p><p class="headingAnchor" id="H12"><span class="h1">HAIR</span><span class="headingEndMark"> — </span>Pregnancy hormonal effects cause both an increase and a decrease in hair growth.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical findings</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Face, trunk, extremities – Hirsutism in pregnancy results from increased levels of ovarian and placental androgens on the pilosebaceous unit. It is noted most frequently on the face but may also be seen on the arms, legs, back, and suprapubic region [<a href="#rid6">6</a>]. (See  <a class="medical medical_review" href="/d/html/7439.html" rel="external">"Pathophysiology and causes of hirsutism"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Scalp – Scalp hair appears thicker or denser during gestation due to slowing of the normal progression of hairs from anagen (the "growing" stage) to telogen (the "resting" stage), thereby creating a relative increase in anagen hair [<a href="#rid13">13</a>].</p><p></p><p class="bulletIndent2">Rarely, late in pregnancy, hair in the frontoparietal area recedes in a mild form of androgenic alopecia [<a href="#rid6">6,13</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Postpartum course</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Face, trunk, extremities – For increased hair growth on the face, trunk, and extremities, the terminal hairs tend to be permanent, whereas the lanugo hairs are likely to regress by six months postpartum [<a href="#rid6">6</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Scalp – For the scalp, the percentage of telogen hairs in the scalp increases one to five months postpartum, thus hair loss (telogen effluvium) is common at this time and scalp hair may become thin [<a href="#rid6">6</a>]. Telogen effluvium resolves within 15 months postpartum [<a href="#rid6">6</a>], but the scalp hair may never be as dense as it was prior to pregnancy. (See  <a class="medical medical_review" href="/d/html/15683.html" rel="external">"Telogen effluvium"</a>.)</p><p></p><p class="bulletIndent2">Androgenic alopecia generally resolves postpartum but may persist. (See  <a class="medical medical_review" href="/d/html/7447.html" rel="external">"Overview of androgen deficiency and therapy in females"</a>.)</p><p></p><p class="headingAnchor" id="H16"><span class="h1">NAILS</span><span class="headingEndMark"> — </span>Nails may grow faster during gestation and might become dystrophic with transverse grooves, subungual keratosis, and distal onycholysis (ie, painless separation of the nail from the nail bed). The nail plate may become soft or brittle [<a href="#rid13">13</a>]; an increase of melanonychia (ie, pigmented streaks in the nail bed) has also been reported. However, in a 2023 survey study, only onychocryptosis (distal-lateral ingrowing of the nail) and leukonychia (opaque, white patches or striae on nail) were reported as more common in pregnant than in nonpregnant patients [<a href="#rid54">54</a>]. (See  <a class="medical medical_review" href="/d/html/121519.html" rel="external">"Longitudinal melanonychia"</a> and  <a class="medical medical_review" href="/d/html/131356.html" rel="external">"Ingrown nails"</a> and  <a class="medical medical_review" href="/d/html/13682.html" rel="external">"Overview of nail disorders", section on 'Leukonychia'</a>.)</p><p class="headingAnchor" id="H17"><span class="h1">MUCOSA AND NONKERATINIZED EPITHELIUM</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vagina</strong> – Bluish/purplish coloration of the vagina ( Chadwick sign) and cervix (Goodell sign) are early anatomic changes historically important in the diagnosis of pregnancy. The blue appearance is related to increased blood flow.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mouth</strong> – Pregnancy-related changes to the oral mucosa are caused by increased levels of sex steroids [<a href="#rid55">55</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Enlargement and blunting of the interdental papillae is common and gingivitis  (<a class="graphic graphic_picture graphicRef82278" href="/d/graphic/82278.html" rel="external">picture 19</a>) may occur or worsen. Prevalence rates of 40 to 100 percent have been reported [<a href="#rid56">56</a>]. The cause of pregnancy-induced gingivitis is likely multifactorial and includes pregnancy hormone-related vascular and inflammatory changes [<a href="#rid57">57-61</a>]. Optimal oral hygiene can reduce gingival swelling, erythema, and bleeding tendencies; therefore, brushing twice daily, flossing daily, and rinsing with an antimicrobial/antiseptic mouthrinse once or twice a day are important. Patients with moderate to severe symptoms should consult with a dental professional. (See  <a class="medical medical_review" href="/d/html/6858.html" rel="external">"Overview of gingivitis and periodontitis in adults"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Other pregnancy-related changes to the oral mucosa include increased gingival probing depths, tooth mobility, and an increased incidence of periodontopathogens, especially <em>Porphyromonas gingivalis</em> and <em>Prevotella intermedia </em>[<a href="#rid62">62</a>].</p><p></p><p class="bulletIndent2">Pyogenic granulomas are also more common in pregnancy. (See <a class="local">'Vascular tumors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nasopharynx</strong> – Many pregnant people experience hyperemia of the membranes of the nasal mucosa and sinuses, which is thought to be related to the hormonal changes of pregnancy. Hyperemia can cause significant, and sometimes uncomfortable, nasal and sinus congestion, but its presence does not necessarily represent pathology. Patients who are particularly bothered by their symptoms may desire treatment, which is reviewed separately. (See  <a class="medical medical_review" href="/d/html/5552.html" rel="external">"Recognition and management of allergic disease during pregnancy", section on 'Rhinitis'</a>.)</p><p></p><p class="headingAnchor" id="H23223859"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/d/html/83982.html" rel="external">"Patient education: Melasma (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H18"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Overview of normal changes in pregnancy</strong> – The normal physiological alterations in skin during pregnancy are listed in the table  (<a class="graphic graphic_table graphicRef78973" href="/d/graphic/78973.html" rel="external">table 1</a>). (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Changes in pigmentation</strong> – Almost all pregnant women develop some degree of increased skin pigmentation. Melasma (ie, chloasma or mask of pregnancy) is the most cosmetically disturbing pigmentary change and occurs in up to 75 percent of pregnant women  (<a class="graphic graphic_picture graphicRef64109" href="/d/graphic/64109.html" rel="external">picture 1</a> and <a class="graphic graphic_picture graphicRef75884" href="/d/graphic/75884.html" rel="external">picture 2</a> and <a class="graphic graphic_picture graphicRef52220" href="/d/graphic/52220.html" rel="external">picture 3</a>). (See <a class="local">'Hyperpigmentation'</a> above and <a class="local">'Melasma'</a> above.)</p><p></p><p class="bulletIndent1">Melasma due to pregnancy usually regresses within one year. Treatment options for postpartum patients who are bothered by persistent melasma include topical skin-lightening agents, oral <a class="drug drug_general" data-topicid="10011" href="/d/drug information/10011.html" rel="external">tranexamic acid</a>, chemical peels, and laser and light therapies. (See  <a class="medical medical_review" href="/d/html/6621.html" rel="external">"Melasma: Management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vascular changes</strong> – Estrogen and other factors cause vascular distention, vascular instability, and proliferation of blood vessels during pregnancy. These vascular alterations result in numerous changes in skin that usually regress postpartum. The changes include vascular spiders  (<a class="graphic graphic_picture graphicRef74047" href="/d/graphic/74047.html" rel="external">picture 6</a>), palmar erythema, varicosities (eg, lower limb, anorectum, vulva), and vascular tumors. (See <a class="local">'Vascular changes'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Striae gravidarum</strong> – Striae gravidarum (stretch marks) are due to connective tissue changes and are most prominent on the abdomen, breasts, and thighs, but also arise on the lower back, buttocks, and upper arms. There is a genetic predisposition to their development. Although striae fade postpartum, they do not disappear. There is no effective method of prevention or treatment. (See <a class="local">'Striae gravidarum'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pruritus</strong> – Pruritus in pregnant women may be physiologic, related to a flare of a disorder present prior to conception, or related to pregnancy-specific dermatoses. Treatment with oatmeal baths, topical steroids, antihistamines, and/or ultraviolet light helps to relieve symptoms. (See <a class="local">'Pruritus'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nevi</strong> – All nevi that change in a manner that would raise concern in the nonpregnant patient should be examined histologically in the pregnant patient. (See <a class="local">'Nevi'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Glands</strong> – Eccrine activity increases (except on the palms), apocrine activity is decreased, and sebaceous gland activity may increase during pregnancy. (See <a class="local">'Skin appendages (eccrine, apocrine, and sebaceous glands)'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hair</strong> – Hirsutism increases during pregnancy. Scalp hair becomes thicker, but the hair line may recede. Postpartum, a temporary period of hair loss is common (ie, telogen effluvium). (See <a class="local">'Hair'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nails</strong> – Nails have historically been reported to grow faster during pregnancy, and sometimes develop transverse grooves, subungual keratosis, distal onycholysis, and melanonychia. The nail plate may become soft or brittle.  However, some researchers report only onychocryptosis and leukonychia as increased in pregnancy. (See <a class="local">'Nails'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mouth and nose</strong> – Most pregnant people note gingival changes and/or gingivitis  (<a class="graphic graphic_picture graphicRef82278" href="/d/graphic/82278.html" rel="external">picture 19</a>). Many experience hyperemia of the mucous membranes of the nasal mucosa and sinuses, which can cause significant, and sometimes uncomfortable, nasal and sinus congestion. (See <a class="local">'Mucosa and nonkeratinized epithelium'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Tyler KH. Physiological skin changes during pregnancy. Clin Obstet Gynecol 2015; 58:119.</a></li><li><a class="nounderline abstract_t">Bieber AK, Martires KJ, Stein JA, et al. Pigmentation and Pregnancy: Knowing What Is Normal. Obstet Gynecol 2017; 129:168.</a></li><li><a class="nounderline abstract_t">Martin AG, Leal-Khouri S. Physiologic skin changes associated with pregnancy. Int J Dermatol 1992; 31:375.</a></li><li><a class="nounderline abstract_t">Murray JC. Pregnancy and the skin. Dermatol Clin 1990; 8:327.</a></li><li><a class="nounderline abstract_t">Kumari R, Jaisankar TJ, Thappa DM. A clinical study of skin changes in pregnancy. Indian J Dermatol Venereol Leprol 2007; 73:141.</a></li><li><a class="nounderline abstract_t">Winton GB, Lewis CW. Dermatoses of pregnancy. J Am Acad Dermatol 1982; 6:977.</a></li><li><a class="nounderline abstract_t">Sanchez NP, Pathak MA, Sato S, et al. Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study. J Am Acad Dermatol 1981; 4:698.</a></li><li><a class="nounderline abstract_t">Geraghty LN, Pomeranz MK. Physiologic changes and dermatoses of pregnancy. Int J Dermatol 2011; 50:771.</a></li><li><a class="nounderline abstract_t">Clark D, Thody AJ, Shuster S, Bowers H. Immunoreactive alpha-MSH in human plasma in pregnancy. Nature 1978; 273:163.</a></li><li><a class="nounderline abstract_t">Estève E, Saudeau L, Pierre F, et al. [Physiological cutaneous signs in normal pregnancy: a study of 60 pregnant women]. Ann Dermatol Venereol 1994; 121:227.</a></li><li><a class="nounderline abstract_t">Muzaffar F, Hussain I, Haroon TS. Physiologic skin changes during pregnancy: a study of 140 cases. Int J Dermatol 1998; 37:429.</a></li><li><a class="nounderline abstract_t">Nakama T, Hashikawa K, Higuchi M, et al. Pigmentary demarcation lines associated with pregnancy. Clin Exp Dermatol 2009; 34:e573.</a></li><li><a class="nounderline abstract_t">Elling SV, Powell FC. Physiological changes in the skin during pregnancy. Clin Dermatol 1997; 15:35.</a></li><li><a class="nounderline abstract_t">Moin A, Jabery Z, Fallah N. Prevalence and awareness of melasma during pregnancy. Int J Dermatol 2006; 45:285.</a></li><li><a class="nounderline abstract_t">Bieber AK, Martires KJ, Driscoll MS, et al. Nevi and pregnancy. J Am Acad Dermatol 2016; 75:661.</a></li><li><a class="nounderline abstract_t">Ellis DL. Pregnancy and sex steroid hormone effects on nevi of patients with the dysplastic nevus syndrome. J Am Acad Dermatol 1991; 25:467.</a></li><li><a class="nounderline abstract_t">Pennoyer JW, Grin CM, Driscoll MS, et al. Changes in size of melanocytic nevi during pregnancy. J Am Acad Dermatol 1997; 36:378.</a></li><li><a class="nounderline abstract_t">Wyon Y, Synnerstad I, Fredrikson M, Rosdahl I. Spectrophotometric analysis of melanocytic naevi during pregnancy. Acta Derm Venereol 2007; 87:231.</a></li><li><a class="nounderline abstract_t">Rubegni P, Sbano P, Burroni M, et al. Melanocytic skin lesions and pregnancy: digital dermoscopy analysis. Skin Res Technol 2007; 13:143.</a></li><li><a class="nounderline abstract_t">Foucar E, Bentley TJ, Laube DW, Rosai J. A histopathologic evaluation of nevocellular nevi in pregnancy. Arch Dermatol 1985; 121:350.</a></li><li><a class="nounderline abstract_t">Sanchez JL, Figueroa LD, Rodriguez E. Behavior of melanocytic nevi during pregnancy. Am J Dermatopathol 1984; 6 Suppl:89.</a></li><li><a class="nounderline abstract_t">Chan MP, Chan MM, Tahan SR. Melanocytic nevi in pregnancy: histologic features and Ki-67 proliferation index. J Cutan Pathol 2010; 37:843.</a></li><li><a class="nounderline abstract_t">Laviv Y, Wang JL, Anderson MP, Kasper EM. Accelerated growth of hemangioblastoma in pregnancy: the role of proangiogenic factors and upregulation of hypoxia-inducible factor (HIF) in a non-oxygen-dependent pathway. Neurosurg Rev 2019; 42:209.</a></li><li><a class="nounderline abstract_t">Walker JL, Wang AR, Kroumpouzos G, Weinstock MA. Cutaneous tumors in pregnancy. Clin Dermatol 2016; 34:359.</a></li><li><a class="nounderline abstract_t">Wilkin JK, Smith JG Jr, Cullison DA, et al. Unilateral dermatomal superficial telangiectasia. Nine new cases and a review of unilateral dermatomal superficial telangiectasia. J Am Acad Dermatol 1983; 8:468.</a></li><li><a class="nounderline abstract_t">Kern P. Sclerotherapy of varicose leg veins. Technique, indications and complications. Int Angiol 2002; 21:40.</a></li><li><a class="nounderline abstract_t">Ross V, Domankevitz Y. Laser leg vein treatment: a brief overview. J Cosmet Laser Ther 2003; 5:192.</a></li><li><a class="nounderline abstract_t">Unadkat SN, Leff DR, Teoh TG, et al. Anorectal symptoms during pregnancy: how important is trimester? Int J Colorectal Dis 2010; 25:375.</a></li><li><a class="nounderline abstract_t">Ferdinande K, Dorreman Y, Roelens K, et al. Anorectal symptoms during pregnancy and postpartum: a prospective cohort study. Colorectal Dis 2018; 20:1109.</a></li><li><a class="nounderline abstract_t">Poskus T, Buzinskienė D, Drasutiene G, et al. Haemorrhoids and anal fissures during pregnancy and after childbirth: a prospective cohort study. BJOG 2014; 121:1666.</a></li><li><a class="nounderline abstract_t">Bell D, Kane PB, Liang S, et al. Vulvar varices: an uncommon entity in surgical pathology. Int J Gynecol Pathol 2007; 26:99.</a></li><li><a class="nounderline abstract_t">Leung SW, Leung PL, Yuen PM, Rogers MS. Isolated vulval varicosity in the non-pregnant state: a case report with review of the treatment options. Aust N Z J Obstet Gynaecol 2005; 45:254.</a></li><li><a class="nounderline abstract_t">Ninia JG, Goldberg TL. Treatment of vulvar varicosities by injection-compression sclerotherapy and a pelvic supporter. Obstet Gynecol 1996; 87:786.</a></li><li><a class="nounderline abstract_t">Cordts PR, Eclavea A, Buckley PJ, et al. Pelvic congestion syndrome: early clinical results after transcatheter ovarian vein embolization. J Vasc Surg 1998; 28:862.</a></li><li><a class="nounderline abstract_t">Scultetus AH, Villavicencio JL, Gillespie DL, et al. The pelvic venous syndromes: analysis of our experience with 57 patients. J Vasc Surg 2002; 36:881.</a></li><li><a class="nounderline abstract_t">Aldulaimi S, Saenz A. A Bleeding Oral Mass in a Pregnant Woman. JAMA 2017; 318:293.</a></li><li><a class="nounderline abstract_t">Arunmozhi U, Priya RS, Kadhiresan R, et al. A Large Pregnancy Tumor of Tongue - A Case Report. J Clin Diagn Res 2016; 10:ZD10.</a></li><li><a class="nounderline abstract_t">Kroumpouzos G, Cohen LM. Dermatoses of pregnancy. J Am Acad Dermatol 2001; 45:1.</a></li><li><a class="nounderline abstract_t">Jafarzadeh H, Sanatkhani M, Mohtasham N. Oral pyogenic granuloma: a review. J Oral Sci 2006; 48:167.</a></li><li><a class="nounderline abstract_t">Løes S, Tornes K. Misinterpretation of histopathological results as an important risk factor for unneeded surgery - case report of a "near miss" event in a pregnant woman. Patient Saf Surg 2008; 2:14.</a></li><li><a class="nounderline abstract_t">Sills ES, Zegarelli DJ, Hoschander MM, Strider WE. Clinical diagnosis and management of hormonally responsive oral pregnancy tumor (pyogenic granuloma). J Reprod Med 1996; 41:467.</a></li><li><a class="nounderline abstract_t">Olsen TG, Helwig EB. Angiolymphoid hyperplasia with eosinophilia. A clinicopathologic study of 116 patients. J Am Acad Dermatol 1985; 12:781.</a></li><li><a class="nounderline abstract_t">Parmley T, O'Brien TJ. Skin changes during pregnancy. Clin Obstet Gynecol 1990; 33:713.</a></li><li><a class="nounderline abstract_t">Kang S, Kim KJ, Griffiths CE, et al. Topical tretinoin (retinoic acid) improves early stretch marks. Arch Dermatol 1996; 132:519.</a></li><li><a class="nounderline abstract_t">Cummings, K, Derbes, VJ. Dermatoses associated with pregnancy. Cutis 1967; 3:120.</a></li><li><a class="nounderline abstract_t">Szczęch J, Wiatrowski A, Hirnle L, Reich A. Prevalence and Relevance of Pruritus in Pregnancy. Biomed Res Int 2017; 2017:4238139.</a></li><li><a class="nounderline abstract_t">Kenyon AP, Tribe RM, Nelson-Piercy C, et al. Pruritus in pregnancy: a study of anatomical distribution and prevalence in relation to the development of obstetric cholestasis. Obstet Med 2010; 3:25.</a></li><li><a class="nounderline abstract_t">Kluger N. Can a mother get a tattoo during pregnancy or while breastfeeding? Eur J Obstet Gynecol Reprod Biol 2012; 161:234.</a></li><li><a class="nounderline abstract_t">Kluger N. Body art and pregnancy. Eur J Obstet Gynecol Reprod Biol 2010; 153:3.</a></li><li><a class="nounderline abstract_t">Douglas MJ, Swenerton JE. Epidural anesthesia in three parturients with lumbar tattoos: a review of possible implications. Can J Anaesth 2002; 49:1057.</a></li><li><a class="nounderline abstract_t">Jacobs VR, Morrison JE Jr, Paepke S, Kiechle M. Body piercing affecting laparoscopy: perioperative precautions. J Am Assoc Gynecol Laparosc 2004; 11:537.</a></li><li><a class="nounderline abstract_t">Vossen AR, van Straalen KR, Prens EP, van der Zee HH. Menses and pregnancy affect symptoms in hidradenitis suppurativa: A cross-sectional study. J Am Acad Dermatol 2017; 76:155.</a></li><li><a class="nounderline abstract_t">Yang CS, Teeple M, Muglia J, Robinson-Bostom L. Inflammatory and glandular skin disease in pregnancy. Clin Dermatol 2016; 34:335.</a></li><li><a class="nounderline abstract_t">Matushansky J, Wang Y, Chang MJ, et al. Nail Changes during Pregnancy: A Cross-Sectional Survey of Patients at an Academic Center. Skin Appendage Disord 2023; 9:27.</a></li><li><a class="nounderline abstract_t">Ramos-E-Silva M, Martins NR, Kroumpouzos G. Oral and vulvovaginal changes in pregnancy. Clin Dermatol 2016; 34:353.</a></li><li><a class="nounderline abstract_t">Lee H, Silness J. Periodental disease in pregnancy. Acta Odontol Scan 1963; 21:533.</a></li><li><a class="nounderline abstract_t">Raber-Durlacher JE, van Steenbergen TJ, Van der Velden U, et al. Experimental gingivitis during pregnancy and post-partum: clinical, endocrinological, and microbiological aspects. J Clin Periodontol 1994; 21:549.</a></li><li><a class="nounderline abstract_t">GUSTAFSSON GT, NILSSON IM. Fibrinolytic activity in fluid from gingival crevice. Proc Soc Exp Biol Med 1961; 106:277.</a></li><li><a class="nounderline abstract_t">Kinnby B, Lecander I, Martinsson G, Astedt B. Tissue plasminogen activator and placental plasminogen activator inhibitor in human gingival fluid. Fibrinolysis 1991; 5:239.</a></li><li><a class="nounderline abstract_t">Kinnby B, Astedt B, Casslen B. Reduction of PAI-2 production in cultured human peripheral blood monocytes by estradiol and progesterone on effect on t-PA, a-PA, and PAI-1. Fibrinolysis 1995; 9:152.</a></li><li><a class="nounderline abstract_t">Kinnby B, Matsson L, Astedt B. Aggravation of gingival inflammatory symptoms during pregnancy associated with the concentration of plasminogen activator inhibitor type 2 (PAI-2) in gingival fluid. J Periodontal Res 1996; 31:271.</a></li><li><a class="nounderline abstract_t">Güncü GN, Tözüm TF, Cağlayan F. Effects of endogenous sex hormones on the periodontium--review of literature. Aust Dent J 2005; 50:138.</a></li></ol></div><div id="topicVersionRevision">Topic 456 Version 34.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25517755" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Physiological skin changes during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27926637" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Pigmentation and Pregnancy: Knowing What Is Normal.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1512085" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Physiologic skin changes associated with pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2191803" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Pregnancy and the skin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17458033" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : A clinical study of skin changes in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7047596" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Dermatoses of pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6787100" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21699510" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Physiologic changes and dermatoses of pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/643080" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Immunoreactive alpha-MSH in human plasma in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7832550" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : [Physiological cutaneous signs in normal pregnancy: a study of 60 pregnant women].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9646127" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Physiologic skin changes during pregnancy: a study of 140 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19489867" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Pigmentary demarcation lines associated with pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9034654" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Physiological changes in the skin during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16533230" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Prevalence and awareness of melasma during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27646736" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Nevi and pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1918487" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Pregnancy and sex steroid hormone effects on nevi of patients with the dysplastic nevus syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9091467" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Changes in size of melanocytic nevi during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17533489" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Spectrophotometric analysis of melanocytic naevi during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17374054" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Melanocytic skin lesions and pregnancy: digital dermoscopy analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3977356" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : A histopathologic evaluation of nevocellular nevi in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6528946" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Behavior of melanocytic nevi during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20015190" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Melanocytic nevi in pregnancy: histologic features and Ki-67 proliferation index.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29027018" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Accelerated growth of hemangioblastoma in pregnancy: the role of proangiogenic factors and upregulation of hypoxia-inducible factor (HIF) in a non-oxygen-dependent pathway.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27265074" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Cutaneous tumors in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6853780" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Unilateral dermatomal superficial telangiectasia. Nine new cases and a review of unilateral dermatomal superficial telangiectasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12515979" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Sclerotherapy of varicose leg veins. Technique, indications and complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14741827" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Laser leg vein treatment: a brief overview.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19921218" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Anorectal symptoms during pregnancy: how important is trimester?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29972721" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Anorectal symptoms during pregnancy and postpartum: a prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24810254" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Haemorrhoids and anal fissures during pregnancy and after childbirth: a prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17197905" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Vulvar varices: an uncommon entity in surgical pathology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15904458" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Isolated vulval varicosity in the non-pregnant state: a case report with review of the treatment options.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8677087" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Treatment of vulvar varicosities by injection-compression sclerotherapy and a pelvic supporter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9808854" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Pelvic congestion syndrome: early clinical results after transcatheter ovarian vein embolization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12422096" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : The pelvic venous syndromes: analysis of our experience with 57 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28719673" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : A Bleeding Oral Mass in a Pregnant Woman.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27891481" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : A Large Pregnancy Tumor of Tongue - A Case Report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11423829" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Dermatoses of pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17220613" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Oral pyogenic granuloma: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18534003" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Misinterpretation of histopathological results as an important risk factor for unneeded surgery - case report of a "near miss" event in a pregnant woman.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8829057" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Clinical diagnosis and management of hormonally responsive oral pregnancy tumor (pyogenic granuloma).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4008683" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Angiolymphoid hyperplasia with eosinophilia. A clinicopathologic study of 116 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2289337" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Skin changes during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8624148" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Topical tretinoin (retinoic acid) improves early stretch marks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Dermatoses associated with pregnancy</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29147651" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Prevalence and Relevance of Pruritus in Pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27582836" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Pruritus in pregnancy: a study of anatomical distribution and prevalence in relation to the development of obstetric cholestasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22326613" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Can a mother get a tattoo during pregnancy or while breastfeeding?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20557995" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Body art and pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12477678" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Epidural anesthesia in three parturients with lumbar tattoos: a review of possible implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15701199" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Body piercing affecting laparoscopy: perioperative precautions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27986138" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Menses and pregnancy affect symptoms in hidradenitis suppurativa: A cross-sectional study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27265071" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Inflammatory and glandular skin disease in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36643198" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Nail Changes during Pregnancy: A Cross-Sectional Survey of Patients at an Academic Center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27265073" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Oral and vulvovaginal changes in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Periodental disease in pregnancy</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7989619" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Experimental gingivitis during pregnancy and post-partum: clinical, endocrinological, and microbiological aspects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13709965" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Fibrinolytic activity in fluid from gingival crevice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Tissue plasminogen activator and placental plasminogen activator inhibitor in human gingival fluid</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Reduction of PAI-2 production in cultured human peripheral blood monocytes by estradiol and progesterone on effect on t-PA, a-PA, and PAI-1</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8814598" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Aggravation of gingival inflammatory symptoms during pregnancy associated with the concentration of plasminogen activator inhibitor type 2 (PAI-2) in gingival fluid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16238210" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Effects of endogenous sex hormones on the periodontium--review of literature.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
